prostaglandin D2 synthase inhibitors (University of Queensland)

N/A

Report date: 2025/03/20 09:14:17
NME

Base Information

Drug Nameprostaglandin D2 synthase inhibitors (University of Queensland)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin-H2 D-isomerase inhibitors
TargetsProstaglandin-H2 D-isomerase
Therapy Area/IndicationsInflammationNeuromuscular DiseasesRhinitis, Allergic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Queensland
China Registration ClassN/A

Develop Information

Active CompaniesUniquest Pty LtdThe University Of Queensland
Inactive CompaniesN/A
Active IndicationsInflammationNeuromuscular DiseasesRhinitis, Allergic +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A